Resources
Did you mean
Sanofi-Aventis (136 results)
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Sanofi Pasteur Commends Saudi Arabia for Being Declared Polio-Free.
- RIYADH, Saudi Arabia, March 4 /PRNewswire/ -- - Sanofi Pasteur Recognized as a key Contributor to Polio Eradication Efforts Sanofi pasteur (NYSE: SNY), the vaccines business of the sanofi-aventis Group, commends the Kingdom of Saudi Arabia for being declared a...
- Research articles 2007-03-04
- Sanofi fighting generic drugs tooth and nail in US courts
- PARIS AFP — The French pharmaceuticals group Sanofi-Aventis is turning to vigorous legal action to protect its best-selling drugs in the United States from cheaper generic competition. "We are sure of our patents," a spokesman for Sanofi-Aventis, the world's third largest drug group, said Wednesday. Sanofi announced it...
- Research articles 2006-08-09
- Sanofi slumps on US criminal probe into generics deal
- PARIS AFP — Shares in Sanofi-Aventis fell sharply on news that a deal it struck to keep a cheaper generic version of its blockbuster drug Plavix off the market was the subject of a US criminal investigation. Shares in Sanofi, a heavyweight on the Paris market, plunged by 3.88...
- Research articles 2006-07-27
- Sanofi-Aventis posts profit gain; share price tumbles on pipeline news
- PARIS AFP — Pharmaceutical group Sanofi-Aventis reported a 26 percent rise in second-quarter net profit from a year ago but its share price fell sharply on a mixed picture for new product prospects. The group posted second-quarter net profit of 1.553 billion euros (1.9 billion dollars), beating analysts' estimates...
- Research articles 2005-08-31
- US authorities clear Sanofi takeover offer for Aventis
- WASHINGTON AFP ? US regulatory authorities conditionally agreed to accept the pending merger of French-German pharmaceutical group Aventis and its smaller French rival Sanofi-Synthelabo into the world's third-largest pharmaceutical group. The Federal Trade Commission agreed to the merger on the condition that the two companies give up key drug...
- Research articles 2004-07-29
- Sanofi says US FTC wants more information on Aventis takeover
- PARIS AFP ? French pharmaceutical group Sanofi-Synthelabo said the US Federal Trade Commission had asked for more information on Sanofi's takeover bid for French-German rival Aventis, to complete an FTC investigation. The FTC's decision would not delay the completion of the offer, expected before the end of the second...
- Research articles 2004-05-05
- Sanofi board discussing details of Aventis bid: source
- PARIS AFP ? The board of French pharmaceutical group Sanofi-Synthelabo was finalising a hostile bid for Franco-German rival Aventis which it was expected to launch on Monday, an informed source told AFP. "The board members are discussing the details of the offer," the source said. The takeover bid...
- Research articles 2004-01-25
- Drug deals deliver.
- Investment advisers are profiting from the reorganizations occurring in the pharmaceutical industry in response to increased demand for cheaper drugs and lower health care costs. Most of the international mergers and acquisitions (M&A) for the first nine months of 1994 have a predominantly transatlantic theme, mirroring the strength of US...
- Research articles 1994-11-01
- Sanofi Eats Merck's Vaccine Business for Lunch; Hopes Pinned on "Gardasil for Boys"
- Merck should have been cheered by the news that the CDC plans to reinstate booster shots of meningitis vaccine for kids because the vaccine supply has come back online. The company, after all, has a large vaccine division. But it is just salt in Merck's wounds. by Jim Edwards
- Blog posts 2009-06-26
- Sanofi Gets the Tax Breaks It Wanted in Vaccine HQ Deal
- Sanofi-Aventis appears to have successfully gotten tax breaks from Upper Saucon in a deal to move its new vaccine division HQ to the Pennsylvania town. In the deal, according to BerksMontNews.com, Sanofi gets: The borders of a "Keystone Opportunity Zone" expanded to encompass its new HQ. ...
- Blog posts 2009-01-01
- Sanofi's Lantus Cancer Scare Shows How Enormous Power Lies With Few Experts
- The cancer scare over Sanofi-Aventis' Lantus shows just how much power over a company's drug sales -- and its stock -- are now concentrated in the hands of a tiny number of experts. Sanofi CEO Chris Viehbacher came out of his corner swinging Monday, saying an article in Study of...
- Blog posts 2009-06-29
- Sanofi Wins Antitrust Suit; Morgan Stanley Raises Outlook
- A day of double good news for Sanofi-Aventis: First, its stock took a nice jump after Morgan Stanley raised its assessment of the company to "overweight" (meaning buy more stocks, not that it's fat). Second, the company beat off an antitrust lawsuit filed by Louisiana Wholesale Drug Co. over the...
- Blog posts 2008-11-24
- The Sanofi-Bristol-Myers Squibb Worst-Case Scenario
- Bristol-Myers Squibb seems to live permanently with the rumor that it is about to be acquired by Sanofi-Aventis. The last time this old saw popped up was in the fall of 2008. At that time BNET said "Perhaps it’s time to consummate this relationship." This time around,...
- Blog posts 2009-02-03
- Sanofi CEO Viehbacher Wants More Cuts; Drug Reps' Necks on the Block
- Sanofi-Aventis's Q4 earnings call tomorrow could set the stage for a dramatic few days at the company, according to Bloomberg, as CEO Chris Viehbacher told analysts and his staff that Sanofi needs to cut operating costs and possibly buy a small or midsize firm. Viehbacher wants to get $1.3 billion...
- Blog posts 2009-02-10
- Shire's Big Gamble on ADHD Drug Vyvanse
- One of the recent unheralded successes of the drug world was Shire Pharmaceuticals' launch of Vyvanse, a new, long-acting treatment for attention deficit and hyperactivity disorder. The fact that so little attention has been paid to Vyvanse is a shame because the take-up of this drug has been impressive --...
- Blog posts 2008-09-04
- Why Can't Sanofi Get That Zentiva Deal Done?
- The M&A chess match going on between Sanofi-Aventis and Zentiva, a Czech Republic-based generic drug maker, is fascinating because it seems that the tiny Czech company is the one in a position of strength. Sanofi's bid was rejected by Zentiva on Wednesday. At first glance, it appears...
- Blog posts 2008-09-05
- Sanofi Gets Jennifer Lopez to Hawk Pentacell Pertussis Vaccine
- Sanofi Pasteur, the vaccines unit of Sanofi-Aventis, has persuaded singer Jennifer Lopez to become its joint spokesperson with the March of Dimes' "the Sounds of Pertussis," campaign. (There's even a video, in which Lopez looks strangely like Law & Order's Mariska Hargitay.) The effort is to persuade...
- Blog posts 2009-04-23
- Sanofi Joins Pfizer in Drug-Based Video Game Business
- Sanofi-Aventis has become the latest drug company to get into the online video game business. This time, it's for its ubiquitous sleeping pill, Ambien CR. The game is called "Silence Your Rooster." The game is part of Sanofi's ad campaign for Ambien, which the Wall Street Journal...
- Blog posts 2008-09-25
- Sanofi Puts Tax Squeeze on Pennsylvania Towns
- Sanofi-Aventis' vaccine division, Sanofi Pasteur, wants to move its HQ from Swiftwater, Pa., to Upper Saucon. But to complete the move, it's holding up the town for tax breaks. Sanofi wants to pay Upper Saucon $200,000 in return for not paying taxes for the next 10 years. The move is...
- Blog posts 2008-12-12
- Sanofi-Aventis HQ Sells for $230 Million
- Sanofi-Aventis leases its North American headquarters in Bridgewater, N.J. Renting is fine for some, but a recent deal indicates that despite the declining real estate market, Sanofi may have been better off buying its 670,000-foot complex. The Sanofi building, owned by SL Green Realty Corp. and Gramercy...
- Blog posts 2008-12-11
- << Previous
- page 1 of 2
- Next >>
Content Types
Refining Tags
- Jim Edwards (15 results)
- Finance (11 results)
- Pfizer Inc. (6 results)
- Business Operations (5 results)
- Sales (5 results)
- Investment (5 results)
- Agence France-Presse (4 results)
- Sanofi-Aventis (4 results)
- Vaccine (4 results)
- Healthcare (4 results)
- Taxes (3 results)
- Sales Strategy (3 results)
- Aventis (3 results)
- Financial Planning (3 results)
- Free Trade (3 results)
